Blackandmed

At one call center in the Philippines, workers help Americans with diabetes or neurological conditions troubleshoot devices that monitor their health. Sometimes they get pressing calls: elderly patients who are...

ST. LOUIS — Kevin Hines has been living in a house without a roof in the days since a tornado devastated his community. He has seen some of his neighbors...

Lurbinectedin showed clinical benefit across therapy lines in SCLC, with best responses seen in later lines and with prior immunotherapy exposure. The post Second-Line & Later Therapies Show Promising Outcomes...

New ASCO data highlight presurgical ctDNA as a relapse predictor in early NSCLC and show surgery improves survival over radiation among veterans. The post Early NSCLC at ASCO: Evaluating New...

CHAT, a novel 18-item patient-reported questionnaire, shows promise as a clinical and research tool for evaluating cough hypersensitivity in chronic cough. The post New Tool Assesses Cough Hypersensitivity in Chronic...

A Stanford-led study shows that a weekend workshop for physicians and their partners significantly reduced burnout and improved relationship satisfaction. The post Couples Retreat Cuts Burnout & Boosts Physician Well-Being...

Test your knowledge of the NLA Scientific Sessions agenda. The post How many times is LDL-C referenced in the NLA Scientific Sessions Agenda? first appeared on Physician’s Weekly.   The...

Real-world data show first-line chemo-immunotherapy improves survival and response rates over chemo alone in extensive-stage SCLC, supporting its broader use. The post Combined Immunotherapy & Chemotherapy Improves Survival in Extensive-Stage...

The 2025 ASCO Annual Meeting showcased new data on therapies for chronic lymphocytic leukemia, including zanubrutinib, acalabrutinib, and liso-cel. The post New Data on CLL Therapies Presented at the 2025...

The National Lipid Association Scientific Sessions 2025 include a focus on severe hypercholesterolemia, including a highlight on familial hypercholesterolemia. The post NLA 2025 to Feature a Focus on Severe Hypercholesterolemia...